Contact inhibition and high cell density deactivate the mammalian target of rapamycin pathway, thus suppressing the senescence program
- PMID: 24889617
- PMCID: PMC4066505
- DOI: 10.1073/pnas.1405723111
Contact inhibition and high cell density deactivate the mammalian target of rapamycin pathway, thus suppressing the senescence program
Abstract
During cell cycle arrest caused by contact inhibition (CI), cells do not undergo senescence, thus resuming proliferation after replating. The mechanism of senescence avoidance during CI is unknown. Recently, it was demonstrated that the senescence program, namely conversion from cell cycle arrest to senescence (i.e., geroconversion), requires mammalian target of rapamycin (mTOR). Geroconversion can be suppressed by serum starvation, rapamycin, and hypoxia, which all inhibit mTOR. Here we demonstrate that CI, as evidenced by p27 induction in normal cells, was associated with inhibition of the mTOR pathway. Furthermore, CI antagonized senescence caused by CDK inhibitors. Stimulation of mTOR in contact-inhibited cells favored senescence. In cancer cells lacking p27 induction and CI, mTOR was still inhibited in confluent culture as a result of conditioning of the medium. This inhibition of mTOR suppressed p21-induced senescence. Also, trapping of malignant cells among contact-inhibited normal cells antagonized p21-induced senescence. Thus, we identified two nonmutually exclusive mechanisms of mTOR inhibition in high cell density: (i) CI associated with p27 induction in normal cells and (ii) conditioning of the medium, especially in cancer cells. Both mechanisms can coincide in various proportions in various cells. Our work explains why CI is reversible and, most importantly, why cells avoid senescence in vivo, given that cells are contact-inhibited in the organism.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
MEK drives cyclin D1 hyperelevation during geroconversion.Cell Death Differ. 2013 Sep;20(9):1241-9. doi: 10.1038/cdd.2013.86. Epub 2013 Jul 12. Cell Death Differ. 2013. PMID: 23852369 Free PMC article.
-
Gerosuppression in confluent cells.Aging (Albany NY). 2014 Dec;6(12):1010-8. doi: 10.18632/aging.100714. Aging (Albany NY). 2014. PMID: 25585637 Free PMC article.
-
CDK4/6-inhibiting drug substitutes for p21 and p16 in senescence: duration of cell cycle arrest and MTOR activity determine geroconversion.Cell Cycle. 2013 Sep 15;12(18):3063-9. doi: 10.4161/cc.26130. Epub 2013 Aug 22. Cell Cycle. 2013. PMID: 23974099 Free PMC article.
-
Cell senescence, rapamycin and hyperfunction theory of aging.Cell Cycle. 2022 Jul;21(14):1456-1467. doi: 10.1080/15384101.2022.2054636. Epub 2022 Mar 31. Cell Cycle. 2022. PMID: 35358003 Free PMC article. Review.
-
Rapamycin and the inhibition of the secretory phenotype.Exp Gerontol. 2017 Aug;94:89-92. doi: 10.1016/j.exger.2017.01.026. Epub 2017 Feb 4. Exp Gerontol. 2017. PMID: 28167236 Review.
Cited by
-
Early and Late Effects of Low-Dose X-ray Exposure in Human Fibroblasts: DNA Repair Foci, Proliferation, Autophagy, and Senescence.Int J Mol Sci. 2024 Jul 28;25(15):8253. doi: 10.3390/ijms25158253. Int J Mol Sci. 2024. PMID: 39125823 Free PMC article.
-
A novel autosomal recessive TERT T1129P mutation in a dyskeratosis congenita family leads to cellular senescence and loss of CD34+ hematopoietic stem cells not reversible by mTOR-inhibition.Aging (Albany NY). 2015 Nov;7(11):911-27. doi: 10.18632/aging.100835. Aging (Albany NY). 2015. PMID: 26546739 Free PMC article.
-
STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence.Cell Cycle. 2017 Feb 16;16(4):319-334. doi: 10.1080/15384101.2016.1259037. Epub 2016 Nov 28. Cell Cycle. 2017. PMID: 27892764 Free PMC article.
-
Sorting-free metabolic profiling uncovers the vulnerability of fatty acid β-oxidation in in vitro quiescence models.Mol Syst Biol. 2022 Sep;18(9):e10716. doi: 10.15252/msb.202110716. Mol Syst Biol. 2022. PMID: 36094015 Free PMC article.
-
Key transporters leading to specific protoporphyrin IX accumulation in cancer cell following administration of aminolevulinic acid in photodynamic therapy/diagnosis.Int J Clin Oncol. 2021 Jan;26(1):26-33. doi: 10.1007/s10147-020-01766-y. Epub 2020 Sep 1. Int J Clin Oncol. 2021. PMID: 32875514 Review.
References
-
- Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 1997;88(5):593–602. - PubMed
-
- Deng Q, Liao R, Wu BL, Sun P. High intensity ras signaling induces premature senescence by activating p38 pathway in primary human fibroblasts. J Biol Chem. 2004;279(2):1050–1059. - PubMed
-
- Demidenko ZN, Blagosklonny MV. Growth stimulation leads to cellular senescence when the cell cycle is blocked. Cell Cycle. 2008;7(21):3355–3361. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous